Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours - Concepedia

Concepedia

Publication | Closed Access

Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours

64

Citations

22

References

2014

Year

Martin R. Weihrauch, Heike Richly, Michael S. von Bergwelt‐Baildon, H. Becker, Manuel Schmidt, Ulrich Hacker, Alexander Shimabukuro‐Vornhagen, Udo Holtick, B. Nokay, Matthias Schroff,

European Journal of Cancer

Toll-like Receptor 9Agonist Mgn1703MedicineMetronomic TherapyImmunologyCancer TreatmentOncologyRadiation OncologyCancer ResearchMetastatic Solid Tumours

References

	Year	Citations

Page 1

Page 1